![Page 1: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/1.jpg)
2013 CTN Web Seminar Series
Produced by: NIDA CTN CCC Training Office"This training has been funded in whole or in part with Federal funds from the National Institute on Drug Abuse,
National Institutes of Health, Department of Health and Human Services, under Contract No.HHSN271201000024C."
GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME
Presented by:Colleen Allen, MPH
Eve Jelstrom, CRNA, MBAFrankie Kropp, MS
November 20, 2013
![Page 2: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/2.jpg)
2
Objectives• Identify critical components of multi-site
trials for effective implementation.• Explain preparation activities and
requirements from stakeholders for site endorsement.
• Consider methods to overcome challenges.
![Page 3: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/3.jpg)
3
Resource Collaborators for Trial Implementation
Node/ RRTC
CCC
DSCCCTN
![Page 4: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/4.jpg)
4
Resource Collaborators for Trial Implementation (continued)
• Composition of the Lead Team– CCTN– Node/RRTC– DSC– CCC
• All in the CTN engage in research; this presentation will focus on the efforts of the Node/RRTC, the Clinical Coordinating Center, and the Data & Statistics Center
![Page 5: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/5.jpg)
5
CRITICAL COMPONENTS OF MULTI-SITE TRIALS
DevelopmentProtocol Approval
Trial Dev’t and LogisticsData ManagementNational Training
Study Start
![Page 6: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/6.jpg)
6
Pre-Implementation Milestones• Development• Protocol Approval• Trial Development and Logistics• Data Management Meeting• National Training• Study Start
![Page 7: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/7.jpg)
7
Timeline from Development to Study Start
Dev’t ProtocolApproval
Nat’l Training
DM Meeting
Study Start
Trial Dev & Logist.
6-8 wks before nat’l trng
4 wks before study start
CCTN Concept Approval CTN Number assignedInitial Budget/revise as neededTimeline Development
Protocol Reviews: PRB, DSMB, Lead Node IRB ApprovalSite SelectionOther Regulatory Submission(s)
Revise eCRFs at DM meetingThen, revise Ops Manual as needed (recruitment materials, logs et. al.) Selected Sites Hiring Staff
Initiation Visits (Node QA/CCC)Site EndorsementsStart Enrollment
Training Doc FormDelegation LogRegulatory Training/Document CollectionSupplies/Meds to sites
Other Study Docs in Dev’t: eCRFs, Ops Manual, QA Plan, SOPsTraining Dev & PlanningMeds, Labs, and Supplies ContractsSites to submit for IRB Approval
![Page 8: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/8.jpg)
8
PREPARATION ACTIVITIES AND REQUIREMENTS
![Page 10: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/10.jpg)
10
DevelopmentNode/RRTC• Protocol development
and improvement
• Budget development
• Protocol Concept Submission
• Cost-benefit ratio for each
study procedure• Expected rate of recruitment
for target N• Number of sites required to
reach target N• Impact of inclusion/exclusion
criteria on recruitment• Potential safety issues and
how they will be managed
![Page 11: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/11.jpg)
11
Development (continued)
CCC• Discuss division of
responsibilities• Consult Lead Team to clarify
elements of the study• Investigate study needs –
medication, packaging, laboratory assessments or other study needs – important for budgeting and cost allocation
• Collaborate on timeline development
DSC• Evaluate required
assessments and data reporting and collection
• Tie assessments and data collection to endpoints, protocol adherence and safety monitoring
• Define requirements and specifications for CRFs
• Use standard forms to streamline and expedite database development
![Page 12: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/12.jpg)
12
Protocol ApprovalNode/RRTC• Update study budget throughout
the approval process• Once approved, begin initial
work on the Ops Manual, the Trial Performance Mgmt/QA plan, Training Plan, Source Doc development, etc.
• With CCC and NIDA identify any additional regulatory requirements that exist and with CCC complete submissions
• Determine # of staff hours for
each procedure• Determine supplies and
training for personnel• Determine costs for travel,
specialty training, etc.• Additional documents may
include OHRP – Prisoner Certification or IND (Investigational New Drug) application or exemption
![Page 14: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/14.jpg)
14
Protocol Approval (continued)
Node/RRTC• Determine and document
site selection process• Present selected sites for
Executive Committee/NIDA approval
• Inform sites once approved
• Site criteria should be
clearly established. Decide targeted sites vs. open call
• Develop site survey documents and track results
• Determine and present budget parameters, and once informed, finalize site-specific study budgets
![Page 15: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/15.jpg)
15
Protocol Approval (continued)
CCC• Processes
– identifying, recruiting, consenting, screening participants
– assessments, and medication management and tracking
• Develop more detailed timeline and chart responsibilities
• Discuss and help develop plans for site needs and resource management
• Discuss management plans for particular study– training, risk, monitoring
• Confirm study specific regulatory requirements
DSC• Begin development and
programming of CRFs• Share drafts of CRFs with
the team for review and input
• Consider planned study workflow:– How performance of
required assessments and data collection/reporting will work into study operations
![Page 17: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/17.jpg)
17
Break for Questions
Alternatively, questions can be directed to the presenter by sending an email to [email protected].
![Page 18: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/18.jpg)
18
TRIAL DEVELOPMENT AND LOGISTICS
![Page 19: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/19.jpg)
19
Trial Development and Logistics
• Coordinate with CCC and DSC to complete– Final drafts of study
documents and management tools
– Final training plan and documentation
– Approval of submitted regulatory materials
– Pre-initiation checklist and teleconferences
• Study documents including the Ops Manual and TPM/QA plans
• Tools including Study logs and checklists, Progress notes
• Provides approved submission materials to sites and posts on LiveLink
Node/RRTC
![Page 20: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/20.jpg)
20
Trial Development and Logistics (continued)
CCC• Collaborate to finalize study
medication, documents, and management tools
• Finalize laboratory, consultant, and vendor contracts
• Finalize Delegation of Authority and Staff Signature Log
• On calls review Pre-Initiation checklists addressing Lead Node, CCC and DSC key items
• Collect protocol wide Regulatory Documents
DSC• Complete and review drafts of
all CRFs prior to data management meeting
• Plan for data management meeting to be held 6-8 weeks prior to National Training Meeting
• Develop AdvantageEDC User’s Guide and CRF Manual, GlobalTrace User’s Guide and AdvantageEDC Practicum
![Page 21: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/21.jpg)
21
Data Management Meeting
• Lead Node works with CCC and DSC to finalize eCRFs and database
• Finalize study guidance documents and tools• Training plan and documentation form to
sites• Lead Node monitors site progress towards
initiation weekly
Node/RRTC
![Page 22: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/22.jpg)
22
Data Management Meeting (continued)
• Integrate Ops Manual with Protocol with CRFs
• Identify source documents• Finalize all study guidance
docs and management tools • Finalize training plans and
Investigator Meeting agenda
• 2 day meeting held 6-8 weeks prior to National Training Meeting
• Critically review CRFs• Identify all changes to CRFs;
required to meet timeline for database completion prior to protocol training
• Trial progress and data status reports planning – LN should provide specifications for reports to the DSC by the time of the National Training
CCC DSC
![Page 23: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/23.jpg)
23
National TrainingNODE/RRTC• Lead Node coordinates with CCC and DSC to
complete all training events• Lead Node tracks completion of training requirements
for all site and node personnel• Lead Node continues monitoring site progress
towards initiation weekly
![Page 24: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/24.jpg)
24
National Training (continued)
CCC• Plan for Training 3-4 months
prior to training.• Finalize Training
Documentation Form for use by sites and approval by Lead Node.
• Decide if Training to occur in person or remotely in consultation with CCTN.
• Develop agenda and timing for on-site and webinar training sessions.
DSC• Final study database to be available at
the time of the National Training Meeting
• Plan to provide training on AdvantageEDC, GlobalTrace , and Good Data Management Practices
• Complete development of the AdvantageEDC User’s Guide and CRF Manual, GlobalTrace User’s Guide, and Practicum
• Issue and grade AdvantageEDC practicum shortly after the training
• Begin to develop Integrity queries• Begin to develop trial progress/data
status reports
![Page 25: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/25.jpg)
25
STUDY START-UP
![Page 26: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/26.jpg)
26
Study Start-up
• Lead Node coordinates with CCC to monitor results of site initiation visits and resolution of outstanding items
• Lead Node transitions pre-initiation teleconferences to study management teleconferences
NODE/RRTC
![Page 27: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/27.jpg)
27
Study-Start Up (continued)
• Initiation visits by QA/Node staff and CCC
• Initiation reports issued• Action Items resolved• Endorsement of each site• Screening and
recruitment begins
• Begin to monitor data quality as soon as first participant is enrolled/randomized– Missing forms– Missing values– Integrity queries
• Begin to generate trial progress and data status report as soon as first participant is enrolled/randomized
CCC DSC
![Page 28: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/28.jpg)
28
Study Startup…
…success achieved when all sites are enrolling.
![Page 29: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/29.jpg)
29
OVERCOME CHALLENGES
![Page 30: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/30.jpg)
30
Challenges• Unforeseen regulatory compliance issues• Keeping up with the timetable• Lack of effective communication• Sites and staff new to CTN research trials• Site may need to drop out of the study
after site selection
![Page 31: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/31.jpg)
31
Tools• Use the tools available
– Timeline Template– Study Budget– Pre-Implementation Calculator
TEMPLATES AVAILABLE ON THE CTN INVESTIGATOR TOOLBOX
AT WWW.CTNDSC2.COM/
![Page 32: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/32.jpg)
32
Recap / Highlights• Begin conversations about details early • Consider the costs • Determine what type of Lead Node you
want to be • Communicate, communicate,
communicate • Don't reinvent the wheel • Reach out to existing resources
![Page 33: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/33.jpg)
33
Q&A – Questions / Comments
Alternatively, questions can be directed to the presenter by sending an email to [email protected].
![Page 34: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/34.jpg)
34
Survey Reminder
Upcoming Webinar
The NIDA CCC encourages all to complete the survey issued to participants directly following this webinar session, as this is the primary collective tool for rating your experience with this and other webinars, and for communicating the interests and needs of CTN members and associates.
SECONDARY ANALYSES FOR CLINICAL TRIALS IN DEVELOPMENT***Note the Date Change***Friday, December 6, 201312:00 pm to 1:30 pm ET
![Page 35: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/35.jpg)
35
A copy of this presentation will be available electronically after this session.
http://ctndisseminationlibrary.org
![Page 36: GETTING MULTI-SITE TRIALS UP AND RUNNING ON TIME](https://reader037.vdocuments.us/reader037/viewer/2022102521/568168e0550346895ddfda71/html5/thumbnails/36.jpg)
36
Thank you for participating.NIDA CTN Web Seminar Series